Keratinocytic Vascular Endothelial Growth Factor as a Novel Biomarker for Pathological Skin Condition
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bae, Ok-Nam | - |
dc.contributor.author | Noh, Minsoo | - |
dc.contributor.author | Chun, Young-Jin | - |
dc.contributor.author | Jeong, Tae Cheon | - |
dc.date.available | 2019-03-08T18:00:21Z | - |
dc.date.issued | 2015-01 | - |
dc.identifier.issn | 1976-9148 | - |
dc.identifier.issn | 2005-4483 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/9982 | - |
dc.description.abstract | Skin is an emerging target tissue in pharmaceutical and cosmetic science. Safety assessment for dermal toxicity is a critical step for development of topically applicable pharmaceutical agents and ingredients in cosmetics. Urgent needs exist to set up toxicity testing methods for dermal safety, and identification of novel biomarkers for pathological cutaneous alteration is highly required. Here we will discuss if vascular endothelial growth factor (VEGF) has a potential as a biomarker for dermal impairment. Experimental and clinical evidences for induction of keratinocytic VEGF under pathological conditions will be reviewed. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | KOREAN SOC APPLIED PHARMACOLOGY | - |
dc.title | Keratinocytic Vascular Endothelial Growth Factor as a Novel Biomarker for Pathological Skin Condition | - |
dc.type | Article | - |
dc.identifier.doi | 10.4062/biomolther.2014.102 | - |
dc.identifier.bibliographicCitation | BIOMOLECULES & THERAPEUTICS, v.23, no.1, pp 12 - 18 | - |
dc.identifier.kciid | ART001944939 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000347510400002 | - |
dc.identifier.scopusid | 2-s2.0-84920054570 | - |
dc.citation.endPage | 18 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 12 | - |
dc.citation.title | BIOMOLECULES & THERAPEUTICS | - |
dc.citation.volume | 23 | - |
dc.type.docType | Review | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Vascular endothelial growth factor (VEGF) | - |
dc.subject.keywordAuthor | Biomarker | - |
dc.subject.keywordAuthor | Keratinocytic damage | - |
dc.subject.keywordAuthor | Dermal toxicity | - |
dc.subject.keywordPlus | PERMEABILITY FACTOR | - |
dc.subject.keywordPlus | FACTOR EXPRESSION | - |
dc.subject.keywordPlus | ULTRAVIOLET-B | - |
dc.subject.keywordPlus | VEGF-C | - |
dc.subject.keywordPlus | EPIDERMAL-KERATINOCYTES | - |
dc.subject.keywordPlus | ATOPIC-DERMATITIS | - |
dc.subject.keywordPlus | FACTOR-ALPHA | - |
dc.subject.keywordPlus | FACTOR GENE | - |
dc.subject.keywordPlus | CULTURED KERATINOCYTES | - |
dc.subject.keywordPlus | HACAT KERATINOCYTES | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.